Noritaka Machii

Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study

Hayato Tanabe, Haruka Saito, Akihiro Kudo et al. · Journal of Clinical Medicine · 2020 · 106 citations · Full text

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial

Atsushi Tanaka, Michio Shimabukuro, Yosuke Okada et al. · Cardiovascular Diabetology · 2017 · 31 citations · Full text

High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes

Haruka Saito, Hayato Tanabe, Akihiro Kudo et al. · Scientific Reports · 2021 · 25 citations · Full text

Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo‐controlled double‐blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi‐center placebo‐controlled double‐blind randomized trial

Atsushi Tanaka, Michio Shimabukuro, Noritaka Machii et al. · Journal of Diabetes Investigation · 2020 · 21 citations · Full text

Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohort from a Japanese general population

Mariko Iwasaki, Akihiro Kudo, Koichi Asahi et al. · Scientific Reports · 2021 · 21 citations · Full text